{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:41:50Z","timestamp":1790451710398,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,22]]},"DOI":"10.7759\/cureus.45787","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:51:29Z","timestamp":1695408689000},"source":"Crossref","is-referenced-by-count":6,"title":["Tenofovir-Induced Renal Dysfunction Among HIV-Infected Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Yogamba M","family":"Shivakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshwar","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Tamene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali P","family":"Mody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser O","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Sri","family":"Penumetcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2019.01021","article-title":"Tenofovir nephrotoxicity among Asians living with HIV: review of the literature","volume":"1","author":"Nishijima T","year":"2019","unstructured":"Nishijima T, Gatanaga H, Oka S. Tenofovir nephrotoxicity among Asians living with HIV: review of the literature. Glob Health Med. 2019, 1:88-94. 10.35772\/ghm.2019.01021","journal-title":"Glob Health Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12899","article-title":"Estimated glomerular filtration rate slopes on tenofovir alafenamide","volume":"21","author":"Ibrahim F","year":"2020","unstructured":"Ibrahim F, Campbell L, Bailey AC, et al.. Estimated glomerular filtration rate slopes on tenofovir alafenamide. HIV Med. 2020, 21:607-12. 10.1111\/hiv.12899","journal-title":"HIV Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.54133\/ajms.v2i.63","article-title":"Renal toxicity of tenofovir: narrative review","volume":"2","author":"Ali HH Aziz TA","year":"2022","unstructured":"Ali HH Aziz TA. Renal toxicity of tenofovir: narrative review. Al-Rafidain J Med Sci. 2022, 2:40-50. 10.54133\/ajms.v2i.63","journal-title":"Al-Rafidain J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02082-3","article-title":"Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study","volume":"21","author":"Hassan MO","year":"2020","unstructured":"Hassan MO, Duarte R, Mabayoje VO, Dickens C, Lasisi AO, Naicker S. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study. BMC Nephrol. 2020, 21:436. 10.1186\/s12882-020-02082-3","journal-title":"BMC Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy10060164","article-title":"Long-term evaluation of changes in kidney function after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients living with HIV","volume":"10","author":"Gilbert JM","year":"2022","unstructured":"Gilbert JM, Vest K, Kish TD. Long-term evaluation of changes in kidney function after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients living with HIV. Pharmacy (Basel). 2022, 10:164. 10.3390\/pharmacy10060164","journal-title":"Pharmacy (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/23259582221134751","article-title":"Risk factors of renal tubular dysfunction in Thai people living with HIV receiving tenofovir disoproxil fumarate","volume":"21","author":"Phuphuakrat A","year":"2022","unstructured":"Phuphuakrat A, Pasomsub E, Chantratita W, Mahasirimongkol S, Disthabanchong S, Sungkanuparph S, Kiertiburanakul S. Risk factors of renal tubular dysfunction in Thai people living with HIV receiving tenofovir disoproxil fumarate. J Int Assoc Provid AIDS Care. 2022, 21:23259582221134751. 10.1177\/23259582221134751","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946202264010","article-title":"Tenofovir-induced renal and bone toxicity: report of two cases and literature review","volume":"64","author":"Fioroti CE","year":"2022","unstructured":"Fioroti CE, Distenhreft JI, Paulino BB, Lacchine K, Ramos DR, Seguro AC, Luchi WM. Tenofovir-induced renal and bone toxicity: report of two cases and literature review. Rev Inst Med Trop Sao Paulo. 2022, 64:e10. 10.1590\/S1678-9946202264010","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.08.1927","article-title":"Tenofovir-induced type II renal tubular acidosis and Fanconi syndrome: a case report","volume":"156","author":"Saeed M","year":"2019","unstructured":"Saeed M, Khan M, Nalamati J. Tenofovir-induced type II renal tubular acidosis and Fanconi syndrome: a case report. Chest. 2019, 156:A1938. 10.1016\/j.chest.2019.08.1927","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11415","article-title":"Clinical images: tenofovir-induced Fanconi syndrome: an uncommon cause of hypophosphatemic osteomalacia","volume":"4","author":"Sahoo RR","year":"2022","unstructured":"Sahoo RR, Wakhlu A. Clinical images: tenofovir-induced Fanconi syndrome: an uncommon cause of hypophosphatemic osteomalacia. ACR Open Rheumatol. 2022, 4:484-5. 10.1002\/acr2.11415","journal-title":"ACR Open Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S308339","article-title":"Tenofovir disoproxil fumarate-associated renal dysfunction among adult people living with HIV at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2019: a comparative retrospective cohort study","volume":"13","author":"Debeb SG","year":"2021","unstructured":"Debeb SG, Muche AA, Kifle ZD, Sema FD. Tenofovir disoproxil fumarate-associated renal dysfunction among adult people living with HIV at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2019: a comparative retrospective cohort study. HIV AIDS (Auckl). 2021, 13:491-503. 10.2147\/HIV.S308339","journal-title":"HIV AIDS (Auckl)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2018.1133","article-title":"Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected Nigerian patients","volume":"8","author":"Ojeh BV","year":"2018","unstructured":"Ojeh BV, Abah IO, Ugoagwu P, Agaba PA, Agbaji OO, Gyang SS. Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected Nigerian patients. Germs. 2018, 8:67-76. 10.18683\/germs.2018.1133","journal-title":"Germs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v19i1.817","article-title":"An overview of tenofovir and renal disease for the HIV-treating clinician","volume":"19","author":"Venter WD","year":"2018","unstructured":"Venter WD, Fabian J, Feldman C. An overview of tenofovir and renal disease for the HIV-treating clinician. South Afr J HIV Med. 2018, 19:817. 10.4102\/sajhivmed.v19i1.817","journal-title":"South Afr J HIV Med"},{"key":"ref13","article-title":"Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments","author":"Hartling L","year":"2012","unstructured":"Hartling L, Hamm M, Milne A, et al.. Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments. Agency for Healthcare Research and Quality, Rockville, MD; 2012."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-20-08","article-title":"Systematic reviews of prevalence and incidence","author":"Munn Z","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Systematic reviews of prevalence and incidence. JBI Manual for Evidence Synthesis.  Aromataris E, Munn Z (ed): Joanna Briggs Institute, Adelaide; 10.46658\/JBIMES-20-08"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","article-title":"Laboratory Monitoring for Adverse Effects of ART","author":"Shalev N","year":"2021","unstructured":"Shalev N, McGowan JP, Fine SM, et al.. Laboratory Monitoring for Adverse Effects of ART. Johns Hopkins University, Baltimore, MD; 2021."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9172607","article-title":"Reduced kidney function in tenofovir disoproxil fumarate based regimen and associated factors: a hospital based prospective observational study in Ethiopian patients","volume":"2019","author":"Yazie TS","year":"2019","unstructured":"Yazie TS, Orjino TA, Degu WA. Reduced kidney function in tenofovir disoproxil fumarate based regimen and associated factors: a hospital based prospective observational study in Ethiopian patients. Int J Nephrol. 2019, 2019:9172607. 10.1155\/2019\/9172607","journal-title":"Int J Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.51847\/kNev4sPshf","article-title":"Nephrotoxicity in patients on tenofovir vs non-tenofovir containing art regimen: An observational study","volume":"13","author":"Agrawal M","year":"2022","unstructured":"Agrawal M, Shrivastava Sh, Khare RL, et al.. Nephrotoxicity in patients on tenofovir vs non-tenofovir containing art regimen: An observational study. Pharmacophore. 2022, 13:23-31. 10.51847\/kNev4sPshf","journal-title":"Pharmacophore"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.418","article-title":"Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea","volume":"34","author":"Lee JE","year":"2019","unstructured":"Lee JE, Lee S, Song SH, Kwak IS, Lee SH. Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea. Korean J Intern Med. 2019, 34:409-17. 10.3904\/kjim.2016.418","journal-title":"Korean J Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2325958218821963","article-title":"Long term exposure to tenofovir disoproxil fumarate-containing antiretroviral therapy is associated with renal impairment in an African cohort of HIV-infected adults","volume":"18","author":"Agbaji OO","year":"2019","unstructured":"Agbaji OO, Abah IO, Ebonyi AO, et al.. Long term exposure to tenofovir disoproxil fumarate-containing antiretroviral therapy is associated with renal impairment in an African cohort of HIV-infected adults. J Int Assoc Provid AIDS Care. 2019, 18:2325958218821963. 10.1177\/2325958218821963","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.07.003","article-title":"Effects of long-term exposure to tenofovir disoproxil fumarate-containing antiretroviral therapy on renal function in HIV-positive Chinese patients","volume":"52","author":"Tan Q","year":"2019","unstructured":"Tan Q, He YH, Yang TT, et al.. Effects of long-term exposure to tenofovir disoproxil fumarate-containing antiretroviral therapy on renal function in HIV-positive Chinese patients. J Microbiol Immunol Infect. 2019, 52:710-9. 10.1016\/j.jmii.2019.07.003","journal-title":"J Microbiol Immunol Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13019","article-title":"Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score","volume":"22","author":"Hsu R","year":"2021","unstructured":"Hsu R, Brunet L, Fusco J, et al.. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score. HIV Med. 2021, 22:325-33. 10.1111\/hiv.13019","journal-title":"HIV Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05308-9","article-title":"Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir","volume":"20","author":"Yilma D","year":"2020","unstructured":"Yilma D, Abdissa A, K\u00e6stel P, et al.. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir. BMC Infect Dis. 2020, 20:582. 10.1186\/s12879-020-05308-9","journal-title":"BMC Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273183","article-title":"Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya","volume":"17","author":"Karoney MJ","year":"2022","unstructured":"Karoney MJ, Koech MK, Njiru EW, Owino Ong'or WD. Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya. PLoS One. 2022, 17:e0273183. 10.1371\/journal.pone.0273183","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1213047\/v1","article-title":"Renal tubular dysfunction among people living with HIV on tenofovir disoproxil fumarate in Uganda: a hospital-based cross-sectional study","author":"Ng'umbi JP","year":"2022","unstructured":"Ng'umbi JP, Nuwagira E, Kanyesigye M, Muhindo R. Renal tubular dysfunction among people living with HIV on tenofovir disoproxil fumarate in Uganda: a hospital-based cross-sectional study. Research Square. 2022, 10.21203\/rs.3.rs-1213047\/v1","journal-title":"Research Square"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001667","article-title":"Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued","volume":"32","author":"Nishijima T","year":"2018","unstructured":"Nishijima T, Mutoh Y, Kawasaki Y, Tomonari K, Kikuchi Y, Gatanaga H, Oka S. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued. AIDS. 2018, 32:179-88. 10.1097\/QAD.0000000000001667","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-019-0227-1","article-title":"Tenofovir-associated kidney disease in Africans: a systematic review","volume":"16","author":"Mtisi TJ","year":"2019","unstructured":"Mtisi TJ, Ndhlovu CE, Maponga CC, Morse GD. Tenofovir-associated kidney disease in Africans: a systematic review. AIDS Res Ther. 2019, 16:12. 10.1186\/s12981-019-0227-1","journal-title":"AIDS Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/177991-tenofovir-induced-renal-dysfunction-among-hiv-infected-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:40Z","timestamp":1707509260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/177991-tenofovir-induced-renal-dysfunction-among-hiv-infected-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.45787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}